Alzheimers

Researchers Studying Psychedelic Drug as Treatment for Alzheimer’s Disease

The Toronto-based biotech company, which is investigating new psychedelic drugs as a treatment for Alzheimer’s disease, recently received approval from Argentine regulators to initiate Phase II clinical trials of its…

Read More